Supervisory Board

The Supervisory Board at Emergence Therapeutics oversees the strategic direction and governance of the company, ensuring alignment with regulatory standards and long-term objectives. Comprised of a Chairman and multiple Supervisory Directors, the board evaluates the performance of executive management, approves major investments, and mitigates potential risks associated with developing novel ADC immunotherapies for cancer treatment.